Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

The currently licensed JYNNEOS vaccine uses a "live attenuated" virus, meaning the virus has been weakened so it cannot cause disease in humans. That attenuation also limits its protective ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...

Depending on the production capacity of manufacturers, agreements for up to 12 million doses through 2025 can be made, according to the statement. The United Nations Children's Fund (UNICEF) has ...

31 (UPI) --A third COVID-19 vaccine will be available shortly as ... nations People in the United States die the earliest and live the sickest lives out of 10 developed countries, even though ...

(Reuters) -The United Nations Children's Fund (UNICEF) has issued an emergency tender to secure mpox vaccines for crisis-hit countries in collaboration with the Gavi vaccine alliance, Africa CDC ...

UNICEF said Saturday that it has launched an emergency tender for mpox vaccines to help countries hardest hit by the recent outbreak of the disease. "The emergency tender is designed to secure ...

New York/Copenhagen — UNICEF today announced that it has issued an emergency tender for the procurement of mpox vaccines. Vaccines can play a critical role in containing the mpox outbreak which ...

This is because the vaccine contains a weakened live virus which in very rare cases is shed by those who receive it and can then evolve into a new form that can start new epidemics. With doctors ...

“The COVID-19 vaccines have had a tremendous positive impact on public health and vaccination continues to be the most effective method for COVID-19 prevention,” Dr. Peter Marks, director of ...

The US Food and Drug Administration on Friday authorized an updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and up. Doses could be available by the end of next week.